10
5
5
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
5/29/2026, 4:11 PM
Summary of Bill SRES 732
This is Senate Resolution 732 of the 119th Congress, introduced on May 14, 2026. The resolution expresses the Senate's support for recognizing over 25 years of evidence and numerous studies demonstrating the safety and efficacy of mifepristone. It calls for equitable, transparent laws and policies regarding access to time-sensitive medication abortion, based on peer-reviewed scientific evidence.
Read the Full Bill
Current Status of Bill SRES 732
Bill SRES 732 is currently in the status of Bill Introduced since May 14, 2026. Bill SRES 732 was introduced during Congress 119 and was introduced to the Senate on May 14, 2026. Bill SRES 732's most recent activity was Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S2309-2310) as of May 14, 2026
Bipartisan Support of Bill SRES 732
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
46Democrat Cosponsors
44Republican Cosponsors
0Unaffiliated Cosponsors
2Policy Area and Potential Impact of Bill SRES 732
Primary Policy Focus
HealthAlternate Title(s) of Bill SRES 732
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Comments

Kole Gray
771
6 days ago
I don't agree with this bill. It's not fair to force people to accept something they don't believe in. It's important to consider all perspectives and not just push one agenda. It's not right to ignore the concerns of those who may be affected by this.
Sponsors and Cosponsors of SRES 732
Latest Bills
Strength in Diversity Act of 2026
Bill S 4535June 3, 2026
Scientific Integrity Act
Bill S 4545June 3, 2026
Stop Fueling Cartel Violence Act
Bill S 4544June 3, 2026
DME Scammer Prevention Act of 2026
Bill HR 8871June 3, 2026
Designating May 2026 as "National Electrical Safety Month" in the United States and supporting the goals and ideals of "National Electrical Safety Month" to raise awareness of electrical hazards in homes, schools, and workplaces and the action citizens can take to protect against electrically related hazards.
Bill HRES 1302June 3, 2026
Oversight and Transparency for Small Business Certifications Act of 2026
Bill HR 8879June 3, 2026
Small Business Cybersecurity Assistance Evaluation Act of 2026
Bill HR 8880June 3, 2026
Servicemember Civilian Transition Support Act
Bill HR 8751June 3, 2026
Secure America Act
Bill S 2June 3, 2026
Improving Home Dialysis Act of 2026
Bill HR 8875June 3, 2026
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Bill HRES 1285May 29, 2026





